Prothena (PRTA) Q2 Earnings and Revenues Miss Estimates

This article was originally published on Nasdaq

Prothena Corporation PRTA reported a second-quarter 2023 loss of $1.03 per share, wider than the Zacks Consensus Estimate of a loss of 92 cents per share. In the year-ago quarter, the clinical-stage company had reported a loss of